Avanza Bank Holding AB (publ) (LON:0NUK)

Ligand Pharmaceuticals Revenue

Avanza Bank Holding AB had revenue of 1.17B SEK in the quarter ending June 30, 2025, with 13.53% growth. This brings the company's revenue in the last twelve months to 4.65B, up 17.55% year-over-year. In the year 2024, Avanza Bank Holding AB had annual revenue of 4.29B with 14.39% growth.

• Revenue (ttm): 4.65B SEK
• Revenue Growth: +17.55%
• P/S Ratio: 12.02
• Revenue / Employee: 6.85M SEK
• Employees: 679
• Market Cap: 4.29B USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.29B	540.00M	14.39%
Dec 31, 2023	3.75B	447.00M	13.52%
Dec 31, 2022	3.31B	-437.00M	-11.68%
Dec 31, 2021	3.74B	1.09B	40.89%
Dec 31, 2020	2.66B	1.26B	90.39%